Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Current Liabilities (2019 - 2025)

Historic Total Current Liabilities for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $22.9 million.

  • Pulmonx's Total Current Liabilities rose 2501.64% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year increase of 2501.64%. This contributed to the annual value of $24.4 million for FY2024, which is 552.75% up from last year.
  • As of Q3 2025, Pulmonx's Total Current Liabilities stood at $22.9 million, which was up 2501.64% from $22.4 million recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Total Current Liabilities ranged from a high of $24.9 million in Q1 2025 and a low of $14.0 million during Q1 2021
  • Over the past 5 years, Pulmonx's median Total Current Liabilities value was $20.4 million (recorded in 2022), while the average stood at $20.0 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first soared by 4641.49% in 2021, then plummeted by 1649.51% in 2024.
  • Quarter analysis of 5 years shows Pulmonx's Total Current Liabilities stood at $17.6 million in 2021, then increased by 5.37% to $18.5 million in 2022, then increased by 25.23% to $23.2 million in 2023, then rose by 5.53% to $24.4 million in 2024, then dropped by 6.38% to $22.9 million in 2025.
  • Its last three reported values are $22.9 million in Q3 2025, $22.4 million for Q2 2025, and $24.9 million during Q1 2025.